2. Zuhlke L., Karthikeyan G., Engel M.E. et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: Two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016; 134(19): 1456–66. http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024769.

3. GBD 2013 Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385(9963): 117–71. http://dx.doi.org/10.1016/S0140-6736(14)61682-2.

4. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation. 1985; 72(6): 1155–62. http://dx.doi.org/10.1161/01.cir.72.6.1155.

5. Oliver J., Osowicki J., Cordell B. et al. Incidence of acute rheumatic fever and rheumatic heart disease in Melbourne, Australia from 1937 to 2013. J Paediatr Child Health. 2020; 56(9): 1408–13. http://dx.doi.org/10.1111/jpc.14950.

6. Tibazarwa K.B., Volmink J.A., Mayosi B.M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart. 2008; 94(12): 1534–40. http://dx.doi.org/10.1136/hrt.2007.141309.

7. Watkins D.A., Johnson C.O., Colquhoun S.M. et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017; 377(8): 713–22. http://dx.doi.org/10.1056/NEJMoa1603693.

8. McCall C. Rheumatic heart disease in the Pacific island nations. Lancet. 2018; 391(10124): 926. http://dx.doi.org/10.1016/S0140-6736(18)30615-9.

9. Gupta R., Panwar R.B., Sharma A. et al. Continuing burden of rheumatic heart disease in India. J Assoc Physicians India. 2020; 68(10): 60–65.

10. Mensah G.A., Roth G.A., Sampson U.K. et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: A systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr. 2015; 26(2 Suppl 1): S6–10. http://dx.doi.org/10.5830/CVJA-2015-036.

11. Кузьмина Н.Н., Медынцева Л.Г., Белов Б.С. Ревматическая лихорадка: полувековой опыт изучения проблемы. Размышления ревматолога. Научно-практическая ревматология. 2017; 55(2): 125–137. [Kuzmina N.N., Medyntseva L.G., Belov B.S. Rheumatic fever: half a century of experience in studying the problem. Reflections of a rheumatologist. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2017; 55(2): 125–137 (In Russ.)] http://dx.doi.org/10.14412/1995-4484-2017-125-137. EDN: YSTSPF.

12. Балабанова Р.М. Заболеваемость населения России острой ревматической лихорадкой и хроническими ревматическими болезнями сердца (2011­2012 гг.). Современная ревматология. 2014; 8(1): 14–21. [Balabanova R.M. The incidence of acute rheumatic fever and chronic rheumatic heart disease in the Russian population (2011–2012). Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014; 8(1): 14–21 (In Russ.)]. http://dx.doi.org/10.14412/1996-7012-2014-1-14-17. EDN: SEUMHD.

13. Савина А.А., Фейгинова С.И. Динамика заболеваемости болезнями системы кровообращения взрослого населения Российской Федерации в 2007–2019 гг. Социальные аспекты здоровья населения. 2021; 67(2): 1. [Savina A.A., Feyginova S.I. Dynamics in incidence of diseases of the circulatory system among adults in the Russian Federation in 2007–2019. Sotsial’nye aspekty zdorov’ia naseleniia = Social Aspects of Population Health. 2021; 67(2): 1 (In Russ.)]. https://dx.doi.org/10.21045/2071-5021-2021-67-2-1. EDN: ZRWFXA.

14. Saxena A., Ramakrishnan S., Roy A. et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart. 2011; 97(24): 2018–22. https://dx.doi.org/10.1136/heartjnl-2011-300792.

15. Zuhlke L.J., Beaton A., Engel M.E. et al. Group A Streptococcus, acute rheumatic fever and rheumatic heart disease: Epidemiology and clinical considerations. Curr Treat Options Cardiovasc Med. 2017; 19(2): 15. https://dx.doi.org/10.1007/s11936-017-0513-y.

16. Санталова Г.В., Гаранин А.А., Лебедев П.А. с соавт. Перспективные подходы к ранней диагностике хронической ревматической болезни сердца. Наука и инновации в медицине. 2022; 7(3): 170–175. [Santalova G.V., Garanin A.A., Lebedev P.A. Promising approaches to early diagnosis of chronic rheumatic heart disease. Nauka i innovatsii v meditsine = Science and Innovations in Medicine. 2022; 7(3): 170–175 (In Russ.)]. https://dx.doi.org/10.35693/2500-1388-2022-7-3-170-175. EDN PUPXEW.

17. Семенов В.Ю., Самородская И.В., Ларина В.Н., Андреев Е.М. Показатели смертности от приобретенных пороков сердца за 15-летний период в Российской Федерации и Соединенных Штатах Америки и анализ факторов, влияющих на их формирование. Креативная кардиология. 2017; 11(3): 235–246. [Semenov V.Yu., Samorodskaia I.V., Larina V.N., Andreev E.M. Mortality from acquired heart disease during a 15 year period in the Russian Federation and the United States and an analysis of the factors influencing their formation. Kreativnaya kardiologiya = Creative Cardiology. 2017; 11(3): 235–46 (In Russ.)]. https://dx.doi.org/10.24022/1997-3187-2017-11-3-235-246. EDN: ZHENWX.

18. Peters F., Karthikeyan G., Abrams J. et al. Rheumatic heart disease: current status of diagnosis and therapy. Cardiovasc Diagn Ther. 2020; 10(2): 305–15. https://dx.doi.org/10.21037/cdt.2019.10.07.

19. Чотчаев Р.М., Доля Е.М. Хроническая ревматическая болезнь сердца, как исход острой ревматической лихорадки, современные представления о патогенезе и распространенности. Вопросы устойчивого развития общества. 2022; 4; 1596–1600. [Chotchaev R.M., Dolya E.M. Chronic rheumatic heart disease as an outcome of acute rheumatic fever, modern concepts of pathogenesis and prevalence. Voprosy ustoychivogo razvitiya obshchestva = Issues of Sustainable Development of Society. 2022; 4; 1596–1600 (In Russ.)]. EDN ZMAUJC.

20. Новичихина А.В. Многоклапанный порок сердца у пациентки с хронической ревматической болезнью сердца. В книге: 72-я Итоговая научная конференция студентов Ростовского государственного медицинского университета. Сборник материалов. Ростов-на Дону: Ростовский государственный медицинский университет. 2018; с. 34–35. [Novichikhina A.V. Multivalvular heart disease in a patient with chronic rheumatic heart disease. In the book: 72nd Final scientific conference of students of the Rostov State Medical University. Collection of materials. Rostov-on-Don: Rostov State Medical University. 2018; pp. 34–35 (In Russ.)]. EDN: HRFZDJ.

21. Mocumbi A.O., Jamal K.K., Mbakwem A. et al. The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease. Cardiovasc J Afr. 2018; 29(6): 394–403. https://dx.doi.org/10.5830/CVJA-2018-04.

22. Горбунова Е.В., Романова М.П., Максимов С.А., Мамчур С.Е. Качество жизни пациентов после электроимпульсной терапии при одномоментной коррекции порока митрального клапана и фибрилляции предсердий. Российский медицинский журнал. 2014; 20(2): 4–7. [Gorbunova E.V., Romanova M.P., Maksimov S.A., Mamtchur S.E. The life quality of patients after electropulse therapy under singlestage correction of mitral valve failure and fi brillation of atriums. Rossiyskiy meditsinskiy zhurnal = Medical Journal of Russia. 2014; 20(2): 4–7 (In Russ.)]. EDN: SCFDYR.

23. Vahanian A., Beyersdorf F., Praz F. et al.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632. https://dx.doi.org/10.1093/eurheartj/ehab395.